RSS Atom • ISSN 1472-4683 • Subscribe • About
Side effects
- One third of HIV positive people at five UK clinics have symptomatic depression: link to adherence and viral suppression – 40% cases are untreated Conference reports - Opportunistic infections and complications - Side effects - BHIVA 18th Birmingham 2012 - 1 May 2012
- Intranasal and topical corticosteroids and risk of Cushing’s symptoms in HIV patients on ritonavir-based combinations Conference reports - PK and drug interactions - Side effects - BHIVA 18th Birmingham 2012 - 1 May 2012
- No association between atazanavir and MI or stroke in D:A:D study Conference reports - Opportunistic infections and complications - Side effects - CROI 19 (Retrovirus) 2012 - 1 April 2012
- Hearing loss not associated with HIV in MACS and WIHS cohorts Conference reports - Opportunistic infections and complications - Side effects - IAS 6 Rome 2011 - 1 August 2011
- More metabolic abnormalities in children receiving a PI compared to NNRTI in NEVEREST study Conference reports - Paediatric care - Side effects - IAS 6 Rome 2011 - Paediatric Workshop 3 Rome 2011 - 1 August 2011
- Lopinavir/ritonavir oral solution toxicity in neonates Conference reports - Paediatric care - Side effects - CROI 18 (Retrovirus) 2011 - 1 August 2011
- Tenofovir associated with fewer side-effect related switches compared to AZT or d4T in first-line treatment Side effects - 1 May 2011
- Meta-analysis of RCTs support use of smoked cannabis to treat HIV-related peripheral neuropathy Side effects - 1 February 2011
- HIV-positive people in the HOPS cohort have 4-fold risk of fracture compared to general population in the US Conference reports - Side effects - CROI 17 (Retrovirus) 2010 - 2 April 2010
- Alendronate improves bone mineral density in HIV-positive people with osteoporosis at 96 weeks Conference reports - Side effects - EACS 12 Cologne 2009 - 21 February 2010
- 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV (IWADR) 26-28 October 2009, Philadelphia Conference reports - Side effects - Conference index - Lipodystrophy Workshop (IWADRW) 11 Philadelphia 2009 - 20 February 2010
- Tenofovir and renal safety Conference reports - Side effects - IAS 5 Cape Town 2009 - 5 October 2009
- Assessing the cardiovascular impact of HIV, abacavir, and new signals for lopinavir/r Conference reports - Side effects - CROI 16 (Retrovirus) 2009 - 3 June 2009
- Intensive smoking cessation programme reports limited success at 6 months Conference reports - Side effects - CROI 16 (Retrovirus) 2009 - 3 June 2009
- HDL particle concentration predicts cardiovascular disease in SMART Conference reports - Side effects - CROI 16 (Retrovirus) 2009 - 3 June 2009
- CD4 count >250 not predictive of rash-associated hepatoxicity among women initiating nevirapine-based ART in Zambia, Thailand, and Kenya Conference reports - Side effects - CROI 16 (Retrovirus) 2009 - 3 June 2009
- Genetic markers linked to early discontinuation of three antiretrovirals Conference reports - Side effects - PK Workshop 10th 2009 - 3 June 2009
- High rate of rash in HIV-negative volunteers combining raltegravir and darunavir Conference reports - Side effects - ICAAC 48th Washington 2008 - 26 December 2008
- Bone loss in SMART study Conference reports - Side effects - ICAAC 48th Washington 2008 - 26 December 2008
- Parathyroid hormone and vitamin D levels in patients using tenofovir Conference reports - Side effects - ICAAC 48th Washington 2008 - 26 December 2008
- Bone problems raised in several UK studies Conference reports - Side effects - BHIVA 14th Belfast 2008 - 30 August 2008
- Tenofovir and indinavir associated with increased risk of chronic renal failure in EuroSIDA study Side effects - 3 July 2007
- Further insight into risk and management of cardiovascular disease (CVD) from D:A:D cohort: no additional benefit of metabolic syndrome diagnosis; new HIV-specific CVD risk equations; increasing uptake of lipid lowering drugs but low smoking cessation Conference reports - Side effects - CROI 14 (Retrovirus) 2007 - 4 April 2007
- Tenofovir did not increase the incidence nephrotoxicity in limited numbers of HIV-positive patients using chemotherapy or HCV-coinfeced patients using ribavirin Cancer and HIV - Conference reports - Side effects - World AIDS 16 Toronto 2006 - 9 September 2006
- Use of HLA-B*5701 genetic testing to reduce abacavir hypersensitivity reactions Conference reports - Side effects - BHIVA 12th Brighton 2006 - 12 May 2006
- Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa Conference reports - Side effects - CROI 13 (Retrovirus) 2006 - 12 May 2006
- D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy Conference reports - Side effects - CROI 13 (Retrovirus) 2006 - 25 March 2006
- Analysis of hepatic events in 2NN study by CD4 entry criteria, levels differences between nevirapine and efavirenz; excess hepatic events in once-daily nevirapine arm linked to single site in Thailand Conference reports - Side effects - EACS 10 Dublin 2005 - 11 February 2006
- Factors associated with sexual dysfunction in HIV patients Conference reports - Side effects - EACS 10 Dublin 2005 - 11 February 2006
- African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects Conference reports - Side effects - ICAAC 45th Washingon 2005 - 10 February 2006
- Predictors of insulin resistance in first year of therapy Conference reports - Side effects - ICAAC 45th Washingon 2005 - 10 February 2006
- Monitoring side effects in resource limited countries Conference reports - Side effects - Lipodystrophy Workshop (IWADRW) 7 Dublin 2005 - 13 December 2005
- Fatigue among HIV-positive patients in the era of highly active antiretroviral therapy Side effects - 13 October 2005
- EMEA statement on metabolic and cardiovascular complications of antiretroviral therapy in HIV-infected patients Side effects - 13 September 2005
- EMEA statement on use of antiretroviral treatment in HIV-patients with hepatic impairment and/or HBV/HCV co-infection Hepatitis coinfection - Side effects - 13 September 2005
- Levels of efavirenz 10-fold above minimum target level despite coadministration with rifampicin Conference reports - PK and drug interactions - Side effects - BHIVA 11th Dublin 2005 - 15 June 2005
- Absolute risk is modest, but cumulative cardiovascular risk of HAART over five years is similar to 'ever smoked': new data on gender and age Conference reports - Side effects - CROI 12 (Retrovirus) 2005 - 18 April 2005
- EuroSIDA shows HIV-HCV coinfected patients more likely to stop HAART because of side effects Conference reports - Side effects - HIV 7 Glasgow 2004 - 29 March 2005
- Endothelial dysfunction similar in ARV-experienced and -naive patients Conference reports - Side effects - Lipodystrophy Workshop (IWADRW) 6 Washington 2004 - 31 January 2005
- Side effects update: hypersensitivity, heart, bones Conference reports - Side effects - ICAAC 44th Washington 2004 - 29 January 2005